Ballicules.com

Progesterone

endogenous

Pronunciation: proe-JES-ter-oen

Progesterone ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Progesterone ballicule

What it isProgesterone-receptor agonist; endometrial protection with estrogen and luteal support.

Why this oneIt is the endogenous hormone rather than a synthetic progestin, with less adverse lipid effect than medroxyprogesterone.

What limits itSedation favors bedtime use. Oral absorption is variable, and the capsule's peanut oil matters in severe allergy.

Progesterone molecular structure (skeletal formula)
Molecular structure: Progesterone

FDA-approved for

FDA label

BOXED WARNING Estrogen plus progestin therapy: increased risk of cardiovascular disorders, breast cancer, and probable dementia; do not use for prevention of cardiovascular disease or dementia.
FDA dosingPopulationStartTargetMax
Prevention of endometrial hyperplasia (postmenopausal, on estrogen)Adult200 mg QHS x12 sequential days per 28-day cycle
Secondary amenorrheaAdult400 mg QHS x10 days

Renal Undefined

Hepatic Undefined

Instructions

Available strengths

Contraindications

Cautions

Adverse reactions

Pregnancy Should not be used during pregnancy (contraindicated); Category B

Lactation Undefined

Cost

Progesterone (ENDOGENOUS)
What pharmacies pay · NADAC 9/30/26
Strength#/mogeneric $/moCostPlus
100 mgcap30 qd$6.87offered
200 mgcap30 qd$12.12offered

Generic entry2001

⚠ BOXED WARNINGS

Principal riskSedation; it is a peanut oil formulation

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability2 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryX

Defining liabilityVenous thromboembolism and hormone-related adverse effects; estrogen also lowers lamotrigine exposure.

Active metabolites

Open Progesterone in the interactive console ↗